08/14/2024
7:08 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
1:45 PM | Aquestive Therapeutics (Issuer)
Kraus Carl N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:26 PM | Aquestive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/25/2024
7:16 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
3:32 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
12:51 PM | Aquestive Therapeutics (Issuer)
MORRIS TIMOTHY E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
12:50 PM | Aquestive Therapeutics (Issuer)
COSTA SANTO J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/21/2024
12:50 PM | Aquestive Therapeutics (Issuer)
Cochran John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
12:50 PM | Aquestive Therapeutics (Issuer)
Krop Julie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
12:51 PM | Aquestive Therapeutics (Issuer)
BROWN GREGORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
12:51 PM | Aquestive Therapeutics (Issuer)
Taglietti Marco (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
4:14 PM | Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
| Form 3/A | |
06/11/2024
11:35 AM | Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/11/2024
11:36 AM | Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:13 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
12:40 PM | Aquestive Therapeutics (Issuer)
Jenkins Abigail L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
12:40 PM | Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
8:08 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:21 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:23 PM | Aquestive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
8:30 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
8:20 AM | Aquestive Therapeutics (Issuer)
Jenkins Abigail L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/24/2024
5:23 AM | Aquestive Therapeutics (Filer)
Aquestive Therapeutics (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
04/24/2024
5:25 AM | Aquestive Therapeutics (Filer)
Aquestive Therapeutics (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
04/23/2024
11:15 PM | Aquestive Therapeutics (Filer)
| Form EFFECT | |
04/03/2024
4:27 PM | Aquestive Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/01/2024
5:21 PM | Aquestive Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G | |
04/01/2024
7:15 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
1:30 PM | Aquestive Therapeutics (Issuer)
Schobel Alexander Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
8:56 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
12:45 PM | Aquestive Therapeutics (Issuer)
Schobel Alexander Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
12:46 PM | Aquestive Therapeutics (Issuer)
Jung Cassie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
12:46 PM | Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
12:47 PM | Aquestive Therapeutics (Issuer)
TOTH A ERNEST JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
12:47 PM | Aquestive Therapeutics (Issuer)
BRAENDER LORI J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
12:47 PM | Aquestive Therapeutics (Issuer)
Boyd Peter E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
12:47 PM | Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:34 AM | Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:35 AM | Aquestive Therapeutics (Issuer)
Boyd Peter E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:35 AM | Aquestive Therapeutics (Issuer)
Jung Cassie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:35 AM | Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Who are Nvidia’s New Silent Partners? (Ad) Nvidia recently became just the third $2 trillion company.
But Nvidia can’t do everything by itself. I call these Nvidia’s “Silent Partners.” |
03/11/2024
9:35 AM | Aquestive Therapeutics (Issuer)
Kraus Carl N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:36 AM | Aquestive Therapeutics (Issuer)
Schobel Alexander Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:36 AM | Aquestive Therapeutics (Issuer)
TOTH A ERNEST JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:36 AM | Aquestive Therapeutics (Issuer)
BRAENDER LORI J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:09 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
4:12 PM | Aquestive Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
2:24 PM | Aquestive Therapeutics (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G | |
12/08/2023
9:46 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
7:51 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
4:04 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
4:20 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
4:22 PM | Aquestive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
7:45 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
11:04 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2023
11:15 PM | Aquestive Therapeutics (Filer)
| Form EFFECT | |
09/20/2023
3:39 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
